Listed

Neurocrine Biosciences Inc

NBIXNasdaqCIK 914475HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$959.0m, Q2 FY2026
Operating income$151.5m, Q2 FY2026
Net income$144.4m, Q2 FY2026
Neurocrine Biosciences Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m499Revenue, Q3 FY2023, three months to 2023-09-30$498.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure515Revenue, Q4 FY2023, three months to 2023-12-31$515.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure515Revenue, Q1 FY2024, three months to 2024-03-31$515.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure590Revenue, Q2 FY2024, three months to 2024-06-30$590.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure622Revenue, Q3 FY2024, three months to 2024-09-30$622.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure628Revenue, Q4 FY2024, three months to 2024-12-31$627.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure573Revenue, Q1 FY2025, three months to 2025-03-31$572.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure688Revenue, Q2 FY2025, three months to 2025-06-30$687.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure795Revenue, Q3 FY2025, three months to 2025-09-30$794.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure806Revenue, Q4 FY2025, three months to 2025-12-31$805.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure815Revenue, Q1 FY2026, three months to 2026-03-31$814.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure959Revenue, Q2 FY2026, three months to 2026-06-30$959.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Cost of revenue$m11.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$11.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure8.5Cost of revenue, Q4 FY2023, three months to 2023-12-31$8.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure7.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$7.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure9.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$9.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure8.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$8.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure9.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$9.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure9.2Cost of revenue, Q1 FY2025, three months to 2025-03-31$9.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure11.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$11.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure14.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$14.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure17.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$17.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure13.8Cost of revenue, Q1 FY2026, three months to 2026-03-31$13.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figurenot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m204Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$204.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure219Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$218.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure243Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$243.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure242Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$242.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure234Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$234.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure288Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$287.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure277Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$276.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure286Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$286.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure292Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$291.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure302Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$301.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure319Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$318.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure440Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$439.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Operating income$m141Operating income, Q3 FY2023, three months to 2023-09-30$141.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure150Operating income, Q4 FY2023, three months to 2023-12-31$150.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure99.3Operating income, Q1 FY2024, three months to 2024-03-31$99.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure145Operating income, Q2 FY2024, three months to 2024-06-30$145.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure184Operating income, Q3 FY2024, three months to 2024-09-30$183.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure142Operating income, Q4 FY2024, three months to 2024-12-31$142.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure23.6Operating income, Q1 FY2025, three months to 2025-03-31$23.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure146Operating income, Q2 FY2025, three months to 2025-06-30$145.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure239Operating income, Q3 FY2025, three months to 2025-09-30$239.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure211Operating income, Q4 FY2025, three months to 2025-12-31$210.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure193Operating income, Q1 FY2026, three months to 2026-03-31$193.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure152Operating income, Q2 FY2026, three months to 2026-06-30$151.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Interest expense$m1.1Interest expense, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-10-31, accession 0000914475-23-000073.Report this figure1.1Interest expense, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-09, accession 0000914475-24-000054. Derived: 12-month figure less the 9-month figure.Report this figure1.1Interest expense, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-01, accession 0000914475-24-000117.Report this figurenot reportednot reportednot reportednot reported0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figurenot reportednot reportednot reported2.9Interest expense, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Income tax$m32.5Income tax, Q3 FY2023, three months to 2023-09-30$32.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure50.5Income tax, Q4 FY2023, three months to 2023-12-31$50.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(8.9)Income tax, Q1 FY2024, three months to 2024-03-31−$8.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure33.6Income tax, Q2 FY2024, three months to 2024-06-30$33.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure60.5Income tax, Q3 FY2024, three months to 2024-09-30$60.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure59.5Income tax, Q4 FY2024, three months to 2024-12-31$59.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure6.8Income tax, Q1 FY2025, three months to 2025-03-31$6.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure52.0Income tax, Q2 FY2025, three months to 2025-06-30$52.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure82.3Income tax, Q3 FY2025, three months to 2025-09-30$82.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure85.7Income tax, Q4 FY2025, three months to 2025-12-31$85.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure48.9Income tax, Q1 FY2026, three months to 2026-03-31$48.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure17.8Income tax, Q2 FY2026, three months to 2026-06-30$17.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Net income$m83.1Net income, Q3 FY2023, three months to 2023-09-30$83.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure148Net income, Q4 FY2023, three months to 2023-12-31$147.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure43.4Net income, Q1 FY2024, three months to 2024-03-31$43.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure65.0Net income, Q2 FY2024, three months to 2024-06-30$65.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure130Net income, Q3 FY2024, three months to 2024-09-30$129.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure103Net income, Q4 FY2024, three months to 2024-12-31$103.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure7.9Net income, Q1 FY2025, three months to 2025-03-31$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure108Net income, Q2 FY2025, three months to 2025-06-30$107.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure210Net income, Q3 FY2025, three months to 2025-09-30$209.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure154Net income, Q4 FY2025, three months to 2025-12-31$153.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure198Net income, Q1 FY2026, three months to 2026-03-31$197.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure144Net income, Q2 FY2026, three months to 2026-06-30$144.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Diluted EPS$ per share0.82Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figurenot reported0.42Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure0.63Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure1.24Diluted EPS, Q3 FY2024, three months to 2024-09-30$1.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figurenot reported0.08Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure1.06Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure2.04Diluted EPS, Q3 FY2025, three months to 2025-09-30$2.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figurenot reported1.91Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure1.39Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Basic EPS$ per share0.85Basic EPS, Q3 FY2023, three months to 2023-09-30$0.85 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figurenot reported0.43Basic EPS, Q1 FY2024, three months to 2024-03-31$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure0.64Basic EPS, Q2 FY2024, three months to 2024-06-30$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure1.28Basic EPS, Q3 FY2024, three months to 2024-09-30$1.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figurenot reported0.08Basic EPS, Q1 FY2025, three months to 2025-03-31$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure1.09Basic EPS, Q2 FY2025, three months to 2025-06-30$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure2.11Basic EPS, Q3 FY2025, three months to 2025-09-30$2.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figurenot reported1.97Basic EPS, Q1 FY2026, three months to 2026-03-31$1.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure1.43Basic EPS, Q2 FY2026, three months to 2026-06-30$1.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure

Balance sheet

Cash and equivalents$332.4m, Q2 FY2026
Shareholders' equity$3.69bn, Q2 FY2026
Neurocrine Biosciences Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m294Cash and equivalents, Q3 FY2023, at 2023-09-30$293.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure251Cash and equivalents, FY2023, at 2023-12-31$251.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-10, accession 0000914475-25-000037.Report this figure396Cash and equivalents, Q1 FY2024, at 2024-03-31$396.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure140Cash and equivalents, Q2 FY2024, at 2024-06-30$139.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure349Cash and equivalents, Q3 FY2024, at 2024-09-30$349.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure233Cash and equivalents, FY2024, at 2024-12-31$233.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-11, accession 0000914475-26-000007.Report this figure194Cash and equivalents, Q1 FY2025, at 2025-03-31$194.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure264Cash and equivalents, Q2 FY2025, at 2025-06-30$264.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure340Cash and equivalents, Q3 FY2025, at 2025-09-30$340.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure713Cash and equivalents, FY2025, at 2025-12-31$713.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure267Cash and equivalents, Q1 FY2026, at 2026-03-31$266.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure332Cash and equivalents, Q2 FY2026, at 2026-06-30$332.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Current assets$m1,650Current assets, Q3 FY2023, at 2023-09-30$1.65bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-31, accession 0000914475-23-000073.Report this figure1,607Current assets, FY2023, at 2023-12-31$1.61bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-10, accession 0000914475-25-000037.Report this figure1,799Current assets, Q1 FY2024, at 2024-03-31$1.80bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-01, accession 0000914475-24-000117.Report this figure1,670Current assets, Q2 FY2024, at 2024-06-30$1.67bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0000914475-24-000181.Report this figure1,877Current assets, Q3 FY2024, at 2024-09-30$1.88bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure1,725Current assets, FY2024, at 2024-12-31$1.72bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-11, accession 0000914475-26-000007.Report this figure1,638Current assets, Q1 FY2025, at 2025-03-31$1.64bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure1,749Current assets, Q2 FY2025, at 2025-06-30$1.75bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure2,158Current assets, Q3 FY2025, at 2025-09-30$2.16bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure2,523Current assets, FY2025, at 2025-12-31$2.52bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure2,436Current assets, Q1 FY2026, at 2026-03-31$2.44bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure1,638Current assets, Q2 FY2026, at 2026-06-30$1.64bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Total assets$m2,848Total assets, Q3 FY2023, at 2023-09-30$2.85bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-31, accession 0000914475-23-000073.Report this figure3,251Total assets, FY2023, at 2023-12-31$3.25bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-10, accession 0000914475-25-000037.Report this figure3,472Total assets, Q1 FY2024, at 2024-03-31$3.47bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-01, accession 0000914475-24-000117.Report this figure3,305Total assets, Q2 FY2024, at 2024-06-30$3.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0000914475-24-000181.Report this figure3,535Total assets, Q3 FY2024, at 2024-09-30$3.54bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure3,719Total assets, FY2024, at 2024-12-31$3.72bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-11, accession 0000914475-26-000007.Report this figure3,688Total assets, Q1 FY2025, at 2025-03-31$3.69bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure3,890Total assets, Q2 FY2025, at 2025-06-30$3.89bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure4,266Total assets, Q3 FY2025, at 2025-09-30$4.27bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure4,632Total assets, FY2025, at 2025-12-31$4.63bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure4,906Total assets, Q1 FY2026, at 2026-03-31$4.91bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure5,359Total assets, Q2 FY2026, at 2026-06-30$5.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Current liabilities$m692Current liabilities, Q3 FY2023, at 2023-09-30$691.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-31, accession 0000914475-23-000073.Report this figure655Current liabilities, FY2023, at 2023-12-31$654.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-10, accession 0000914475-25-000037.Report this figure713Current liabilities, Q1 FY2024, at 2024-03-31$712.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-01, accession 0000914475-24-000117.Report this figure399Current liabilities, Q2 FY2024, at 2024-06-30$398.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0000914475-24-000181.Report this figure430Current liabilities, Q3 FY2024, at 2024-09-30$429.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure508Current liabilities, FY2024, at 2024-12-31$507.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-11, accession 0000914475-26-000007.Report this figure523Current liabilities, Q1 FY2025, at 2025-03-31$522.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure546Current liabilities, Q2 FY2025, at 2025-06-30$546.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure638Current liabilities, Q3 FY2025, at 2025-09-30$638.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure743Current liabilities, FY2025, at 2025-12-31$743.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure832Current liabilities, Q1 FY2026, at 2026-03-31$831.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure875Current liabilities, Q2 FY2026, at 2026-06-30$874.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Total liabilities$m846Total liabilities, Q3 FY2023, at 2023-09-30$846.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-10-31, accession 0000914475-23-000073.Report this figure1,019Total liabilities, FY2023, at 2023-12-31$1.02bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-10, accession 0000914475-25-000037.Report this figure1,086Total liabilities, Q1 FY2024, at 2024-03-31$1.09bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-01, accession 0000914475-24-000117.Report this figure796Total liabilities, Q2 FY2024, at 2024-06-30$795.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0000914475-24-000181.Report this figure816Total liabilities, Q3 FY2024, at 2024-09-30$816.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure1,129Total liabilities, FY2024, at 2024-12-31$1.13bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-11, accession 0000914475-26-000007.Report this figure1,152Total liabilities, Q1 FY2025, at 2025-03-31$1.15bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure1,196Total liabilities, Q2 FY2025, at 2025-06-30$1.20bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure1,262Total liabilities, Q3 FY2025, at 2025-09-30$1.26bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure1,378Total liabilities, FY2025, at 2025-12-31$1.38bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure1,499Total liabilities, Q1 FY2026, at 2026-03-31$1.50bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure1,666Total liabilities, Q2 FY2026, at 2026-06-30$1.67bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure
Shareholders' equity$m2,002Shareholders' equity, Q3 FY2023, at 2023-09-30$2.00bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure2,232Shareholders' equity, FY2023, at 2023-12-31$2.23bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-11, accession 0000914475-26-000007.Report this figure2,386Shareholders' equity, Q1 FY2024, at 2024-03-31$2.39bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure2,509Shareholders' equity, Q2 FY2024, at 2024-06-30$2.51bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure2,719Shareholders' equity, Q3 FY2024, at 2024-09-30$2.72bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure2,590Shareholders' equity, FY2024, at 2024-12-31$2.59bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure2,536Shareholders' equity, Q1 FY2025, at 2025-03-31$2.54bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure2,694Shareholders' equity, Q2 FY2025, at 2025-06-30$2.69bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure3,004Shareholders' equity, Q3 FY2025, at 2025-09-30$3.00bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure3,253Shareholders' equity, FY2025, at 2025-12-31$3.25bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure3,407Shareholders' equity, Q1 FY2026, at 2026-03-31$3.41bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure3,694Shareholders' equity, Q2 FY2026, at 2026-06-30$3.69bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure

Cash flow

Operating cash flow$136.4m, Q2 FY2026
Capital expenditure$7.8m, Q2 FY2026
Share repurchases$12.0m, Q2 FY2026
Neurocrine Biosciences Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m212Operating cash flow, Q3 FY2023, three months to 2023-09-30$212.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-30, accession 0000914475-24-000211. Derived: 9-month figure less the 6-month figure.Report this figure124Operating cash flow, Q4 FY2023, three months to 2023-12-31$123.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure130Operating cash flow, Q1 FY2024, three months to 2024-03-31$130.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure64.6Operating cash flow, Q2 FY2024, three months to 2024-06-30$64.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0000914475-25-000158. Derived: 6-month figure less the 3-month figure.Report this figure158Operating cash flow, Q3 FY2024, three months to 2024-09-30$158.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0000914475-25-000181. Derived: 9-month figure less the 6-month figure.Report this figure243Operating cash flow, Q4 FY2024, three months to 2024-12-31$242.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure64.8Operating cash flow, Q1 FY2025, three months to 2025-03-31$64.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure102Operating cash flow, Q2 FY2025, three months to 2025-06-30$102.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0000914475-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure228Operating cash flow, Q3 FY2025, three months to 2025-09-30$227.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0000914475-25-000181. Derived: 9-month figure less the 6-month figure.Report this figure388Operating cash flow, Q4 FY2025, three months to 2025-12-31$388.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure146Operating cash flow, Q1 FY2026, three months to 2026-03-31$145.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure136Operating cash flow, Q2 FY2026, three months to 2026-06-30$136.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0000914475-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m7.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$7.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-30, accession 0000914475-24-000211. Derived: 9-month figure less the 6-month figure.Report this figure5.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$5.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure11.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$11.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure11.6Capital expenditure, Q2 FY2024, three months to 2024-06-30$11.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0000914475-25-000158. Derived: 6-month figure less the 3-month figure.Report this figure8.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$8.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0000914475-25-000181. Derived: 9-month figure less the 6-month figure.Report this figure7.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$7.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure10.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$10.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure12.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$12.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0000914475-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure13.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$13.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0000914475-25-000181. Derived: 9-month figure less the 6-month figure.Report this figure(2.4)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure9.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$9.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure7.8Capital expenditure, Q2 FY2026, three months to 2026-06-30$7.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0000914475-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reported0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-30, accession 0000914475-25-000158. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-28, accession 0000914475-25-000181. Derived: 9-month figure less the 6-month figure.Report this figure300Share repurchases, Q4 FY2024, three months to 2024-12-31$300.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure150Share repurchases, Q1 FY2025, three months to 2025-03-31$150.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure17.7Share repurchases, Q2 FY2025, three months to 2025-06-30$17.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-31, accession 0000914475-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-28, accession 0000914475-25-000181. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-11, accession 0000914475-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure54.0Share repurchases, Q1 FY2026, three months to 2026-03-31$54.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure12.0Share repurchases, Q2 FY2026, three months to 2026-06-30$12.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-31, accession 0000914475-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)104.20m, Q2 FY2026
Neurocrine Biosciences Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares99.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3099,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-31, accession 0000914475-23-000073.Report this figure97.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3197,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-01, accession 0000914475-24-000117.Report this figure100Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30100,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0000914475-24-000181.Report this figure101Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30101,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-30, accession 0000914475-24-000211.Report this figure104Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31103,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0000914475-25-000100.Report this figure104Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30103,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0000914475-25-000158.Report this figure104Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30104,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure103Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31102,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure101Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30101,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure103Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30102,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0000914475-25-000181.Report this figure103Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31103,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0000914475-26-000026.Report this figure104Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30104,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure

Shares outstanding: 101.65mShares outstanding, period not labelled, at 2026-07-22101,649,181 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-31, accession 0000914475-26-000037.Report this figure at Jul 22, 2026, from the cover of the 10-Q filed Jul 31, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. Listed shows no prices and gives no investment advice.